Who owns SRPT?
Institutional ownership of Sarepta Therapeutics Inc. from Form 13F, Q2 2026
323 institutional managers reported holding Sarepta Therapeutics Inc. (SRPT) in Form 13F filings for Q2 2026, with 108,003,608 shares worth $1.9B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 5,303,751 shares (+5.2%). 47 opened new positions and 62 sold out.
- Funds holding
- 323
- Value held
- $1.9B
- New / sold out
- 47 / 62
- Net shares, same filers
- +5.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of SRPT
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $341M | 17.6% | 18,994,958 | Added |
| State Street Corp | $160M | 8.3% | 8,916,090 | Added |
| Vanguard Portfolio Management LLC | $151M | 7.8% | 8,377,470 | Added |
| Two Sigma Investments, LP | $82.6M | 4.3% | 4,598,735 | Added |
| Vanguard Capital Management LLC | $82.5M | 4.3% | 4,591,755 | Added |
| First Trust Advisors LP | $78.5M | 4.0% | 4,365,951 | Added |
| AQR Capital Management LLC | $76.9M | 4.0% | 4,325,689 | Trimmed |
| Geode Capital Management, LLC | $49.8M | 2.6% | 2,771,758 | Added |
| Erste Asset Management GmbH | $45.5M | 2.4% | 2,568,945 | Trimmed |
| Marshall Wace, LLP | $39.6M | 2.0% | 2,206,022 | Added |
| Morgan Stanley | $39.6M | 2.0% | 2,202,641 | Trimmed |
| Aberdeen Group plc | $39.4M | 2.0% | 2,194,948 | Trimmed |
| Bank of America Corp | $36.9M | 1.9% | 2,055,985 | Trimmed |
| Goldman Sachs Group Inc | $36.7M | 1.9% | 2,042,501 | Added |
| UBS Group AG | $29.2M | 1.5% | 1,624,415 | Trimmed |
| Federated Hermes, Inc. | $28.6M | 1.5% | 1,590,331 | Trimmed |
| Northern Trust Corp | $21.8M | 1.1% | 1,210,732 | Added |
| Millennium Management LLC | $21.4M | 1.1% | 1,193,468 | Trimmed |
| T. Rowe Price Investment Management, Inc. | $20.8M | 1.1% | 1,156,083 | Added |
| Citigroup Inc | $20.8M | 1.1% | 1,155,006 | Added |
| Renaissance Technologies LLC | $20.2M | 1.0% | 1,121,378 | Trimmed |
| Charles Schwab Investment Management Inc | $17.6M | 0.9% | 980,321 | Added |
| Connor, Clark & Lunn Investment Management Ltd. | $17.5M | 0.9% | 973,493 | Trimmed |
| Assenagon Asset Management S.A. | $16.3M | 0.8% | 908,750 | New |
| Invesco Ltd. | $16.2M | 0.8% | 903,379 | Added |
Share of 13F holdings is each fund's shares as a share of the 108,003,608 SRPT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$76.2M
- State Street Corp Added+$41.4M
- Vanguard Portfolio Management LLC Added+$31.2M
- Marshall Wace, LLP Added+$26.6M
- Goldman Sachs Group Inc Added+$17.3M
- Assenagon Asset Management S.A. New+$16.3M
- Geode Capital Management, LLC Added+$14.1M
- Qube Research & Technologies Ltd New+$11.0M
- Mackenzie Financial Corp Added+$9.8M
- Point72 Asset Management, L.P. New+$9.2M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Sold out-$84.9M
- AQR Capital Management LLC Trimmed-$37.4M
- Canada Pension Plan Investment Board Trimmed-$21.1M
- Citadel Advisors LLC Sold out-$14.2M
- UBS Group AG Trimmed-$10.9M
- Susquehanna International Group, LLP Trimmed-$10.4M
- D. E. Shaw & Co., Inc. Sold out-$10.3M
- Renaissance Technologies LLC Trimmed-$9.8M
- Jacobs Levy Equity Management, Inc Sold out-$8.1M
- Healthcare of Ontario Pension Plan Trust Fund Sold out-$7.9M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $396M and sold $327M; 97 added and 116 trimmed.
Schedule 13D and 13G filings on SRPT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Sarepta Therapeutics Inc.Schedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Sarepta Therapeutics Inc.Schedule 13G
- 2025-11-10STATE STREET CORP SCHEDULE 13G filed by Sarepta Therapeutics Inc.Schedule 13G
- 2025-07-25D. E. SHAW & CO, L.P. SCHEDULE 13G filed by Sarepta Therapeutics Inc.Schedule 13G
Questions about SRPT ownership
- Who owns SRPT stock?
- 323 institutional investment managers reported SRPT positions in their Form 13F filings for Q2 2026, holding 108,003,608 shares worth $1.9B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling SRPT?
- In Q2 2026, 47 managers opened new SRPT positions, 97 added, 116 trimmed and 62 sold out. Managers that filed in both quarters added a net 5,303,751 shares.
- How current is this SRPT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to SRPT by CUSIP. Options are left out. SRPT news and filings · SRPT insider trades · Top funds